UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.49B
Cap. Flow %
-16.94%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.77%
3 Healthcare 15.9%
4 Miscellaneous 8.89%
5 Real Estate 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZWRK
426
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$2.81M 0.03%
285,150
-28,667
-9% -$282K
2021 Q2
5 quarters
SPCM icon
427
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$2.81M 0.03%
275,741
-27,604
-9% -$279K
2022 Q2
1 quarter
BZAI icon
428
Blaize Holdings
BZAI
$35.3M
$2.81M 0.03%
280,744
-28,105
-9% -$280K
2022 Q1
2 quarters
HMA
429
DELISTED
Heartland Media Acquisition Corp.
HMA
$2.81M 0.03%
280,744
-28,105
-9% -$280K
2022 Q1
2 quarters
TGR
430
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$2.8M 0.03%
275,741
-27,604
-9% -$278K
2022 Q2
1 quarter
SO icon
431
Southern Company
SO
$103B
$2.79M 0.03%
+41,059
New +$3.11M
2022 Q3
0 quarters
CC icon
432
Chemours
CC
$1.93B
$2.76M 0.03%
112,121
-81,373
-42% -$2.68M
2020 Q4
7 quarters
ROIC icon
433
DELISTED
Retail Opportunity Investments Corp.
ROIC
$2.76M 0.03%
200,612
-107,016
-35% -$1.77M
2021 Q2
5 quarters
UTHR icon
434
United Therapeutics
UTHR
$23.2B
$2.76M 0.03%
13,162
+4,900
+59% +$1.1M
2022 Q1
2 quarters
RVNC icon
435
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.73M 0.03%
101,179
-74,000
-42% -$1.5M
2022 Q1
2 quarters
BCRX icon
436
BioCryst Pharmaceuticals
BCRX
$2.06B
$2.73M 0.03%
216,327
-20,000
-8% -$257K
2022 Q1
2 quarters
SDST icon
437
Stardust Power Inc
SDST
$378K
$2.73M 0.03%
27,368
-2,867
-9% -$284K
2021 Q1
6 quarters
DOCS icon
438
Doximity
DOCS
$5.33B
$2.72M 0.03%
90,000
-10,000
-10% -$366K
2021 Q2
5 quarters
BSX icon
439
Boston Scientific
BSX
$62.3B
$2.71M 0.03%
70,005
-63,000
-47% -$2.53M
2022 Q1
2 quarters
SLAM icon
440
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.71M 0.03%
273,608
-250,216
-48% -$2.47M
2021 Q2
5 quarters
SANB
441
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
$2.71M 0.03%
267,649
– –
2021 Q4
3 quarters
GLHA
442
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$2.71M 0.03%
275,741
-27,604
-9% -$271K
2022 Q2
1 quarter
TWTR
443
PUT
DELISTED
Twitter, Inc.
TWTR
$2.71M 0.03%
455,100
+900
+0.2% +$36.6K
2022 Q2
1 quarter
SCOB
444
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$2.71M 0.03%
272,086
-27,339
-9% -$270K
2021 Q2
5 quarters
AXGN icon
445
Axogen
AXGN
$2.06B
$2.69M 0.03%
225,477
+40,000
+22% +$400K
2022 Q1
2 quarters
ADER
446
DELISTED
26 Capital Acquisition Corp
ADER
$2.69M 0.03%
272,208
-27,250
-9% -$269K
2022 Q1
2 quarters
HIW icon
447
Highwoods Properties
HIW
$3.14B
$2.69M 0.03%
+99,622
New +$3.22M
2022 Q3
0 quarters
PSAG
448
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$2.68M 0.03%
272,840
-27,314
-9% -$268K
2021 Q2
5 quarters
PHYT icon
449
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$2.67M 0.03%
262,511
– –
2022 Q1
2 quarters
VSAC icon
450
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.66M 0.03%
262,486
-26,277
-9% -$265K
2022 Q1
2 quarters

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.